Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 146 results found. Search for [ COVID-19 vaccine safety concerns ]

Results 1 to 21 of 146
Reuters
May 6, 2021
Moderna had in February forecast vaccine sales of $18.4 billion. Earlier this week, larger rival Pfizer Inc said it expects $26 billion in sales of its COVID-19 vaccine this year


PTI
May 6, 2021
Providing raw materials for the production of anti-coronavirus vaccines was a major component of the Biden administration's announcement on medical aid to India


PTI
May 4, 2021
COVAX urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX's main supplier of the AstraZeneca product is based, according to WHO


Rashi Bisaria
New Delhi, May 4, 2021
Assured India no safety concerns with COVID-19 vaccine: Pfizer Pfizer said it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as India insists on small local trials for foreign shots despite a record surge in infections and shortage of doses. Pfizer, Johnson & Johnson and Moderna have been invited to sell their vaccines to India but none have applied to do so yet. Pfizer, however, is holding fresh talks with the government after having withd...


Reuters
May 4, 2021
Pfizer said it is holding fresh talks with the government after having withdrawn its initial application in February over the earlier local trial rule


BusinessToday.In
May 2, 2021
Assembly Election Result Highlights: TMC demands recounting of votes in Nandigram constituency from where West Bengal CM Mamata Banerjee had contested. The party alleged illegalities in vote counting process.


Reuters
April 19, 2021
Sarah Walters, AstraZeneca's Austria country manager said so far, indicating the existing AstraZeneca vaccine was less effective against the more infectious variant first documented in South Africa were \"too small to draw final conclusions\"


Reuters
April 17, 2021
The Joint Committee on Vaccination and Immunisation (JCVI) said around 90,000 pregnant women had been vaccinated in the United States, mainly with the two American vaccines, without any safety concerns being raised


Reuters
April 15, 2021
Results of investigations into the AstraZeneca-associated blood clots \"showed real and serious side effects,\" Danish health agency head Soren Brostrom told a news briefing


Reuters
April 14, 2021
The vaccine maker said the six-month follow-up of its original late-stage study of the vaccine showed that vaccine efficacy remained consistent with its previous updates


Associated Press
April 14, 2021
The Johnson & Johnson pause, which regulators say they hope to resolve within days, comes on the heels of production issues at the Baltimore plant that produces the J&J vaccine


BusinessToday.In
April 12, 2021
Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia's Sputnik V may get SEC's nod first


BusinessToday.In
April 11, 2021
Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharma companies such as Dr Reddy's Laboratories, Hetero Biopharma, Gland Pharma, Stelis Biopharma and Vichrow Biotech for the production of Sputnik V


PB Jayakumar
April 9, 2021
WHO Global Advisory Committee on Vaccine Safety said in an interim statement the relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible, but is not confirmed


Rashi Bisaria
New Delhi, April 9, 2021
Australia, Philippines, African Union ban AstraZeneca's COVID-19 shotAustralia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world. The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concerns and supply problems since Phase III tria...


Reuters
April 9, 2021
The Philippines suspended the use of AstraZeneca shots for people under age 60 after Europe's regulator said on Wednesday it found rare cases of blood clots among some adult recipients, although it still believes that the vaccine's benefits outweighed its risks


Reuters
April 7, 2021
The European Medicines Agency (EMA) is currently reviewing reports of an extremely rare brain blood clot known as cerebral venous sinus thrombosis (CVST) after the AstraZeneca shots


BusinessToday.In
April 1, 2021
The vaccine was also effective in South Africa, where B.1.351 lineage of the virus is prevalent. It said nine cases of COVID-19 were observed in the country, all in the placebo group.


Associated Press
March 30, 2021
The National Advisory Committee on Immunization had recommended the pause for safety reasons and the Canadian provinces, which administer health in the country, announced the suspension Monday


BusinessToday.In
March 23, 2021
The US will issue authorisation and guidelines for the AstraZeneca COVID-19 vaccine after thorough review of the trial data by independent advisory committees, NIAID stated


PAGES 1 OF 8  12345